Jump to content

File:BNT162b2 vaccine efficacy data.png

Page contents not supported in other languages.
This is a file from the Wikimedia Commons
From Wikipedia, the free encyclopedia

Original file (1,120 × 860 pixels, file size: 127 KB, MIME type: image/png)

Summary

Description
English: Cumulative incidence curves for the first COVID-19 occurrence after first dose of Tozinameran (BNT162b2) or placebo (all-available efficacy population) in double-blind clinical trial submitted to the U.S. FDA for EUA by Pfizer-BioNTech. (red: placebo; blue: BNT162b2)
Date
Source https://www.fda.gov/media/144245/download (p30)
Author U.S Food and Drug Administration and Pfizer Inc.

Licensing

Public domain This chart is ineligible for copyright and therefore in the public domain, because it consists entirely of information that is common property and contains no original authorship. For more information, see Commons:Threshold of originality § Charts

العربية | Deutsch | English | español | français | italiano | 日本語 | македонски | română | русский | slovenščina | 中文(简体) | 中文(繁體) | +/−

Captions

Cumulative incidence curves for symptomatic COVID-19 infections after the first dose of Tozinameran (BNT162b2) or placebo in double-blind clinical trial. (red: placebo; blue: BNT162b2)

Items portrayed in this file

depicts

image/png

108f10c7ddcb6d5736dcc6e774c2b09eaf1c2ce6

129,551 byte

860 pixel

1,120 pixel

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current08:08, 1 January 2021Thumbnail for version as of 08:08, 1 January 20211,120 × 860 (127 KB)WikmozUploaded a work by U.S Food and Drug Administration and Pfizer Inc. from https://www.fda.gov/media/144245/download (p30) with UploadWizard

Global file usage